Trastuzumab Deruxtecan + Stereotactic Radiosurgery (SRS) in HER2+ Breast Cancer Brain Metastases

Clinical trial NCT07454668 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07454668
Sponsor: Baptist Health South Florida
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Cancer HER2-positive Breast Cancer Brain Metastases Cancer Cancer Metastatic

Start date: 2026-06-01
Primary completion: 2028-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.